Resmed wins FDA clearance for AI-enabled personalized CPAP therapy device
December 8, 2025
Resmed (NYSE: RMD)+
announced today that it received FDA clearance for its Smart Comfort personalized therapy offering.
Resmed (NYSE: RMD)+
announced today that it received FDA clearance for its Smart Comfort personalized therapy offering.
Healthcare professionals can access the 1Bio AI-Acute toolbox via the company’s 1Bio platform.
Cancer isn’t just about broken genes—it’s about broken architecture. Imagine a city where roads suddenly vanish, cutting off neighborhoods from essential services. That’s what happens inside cells when the 3D structure of DNA collapses.
SURREY, BC, Dec. 4, 2025 /PRNewswire/ – mlHealth 360 today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K250694) for Scaida BrainCT-ICH, an AI-powered triage solution designed to address critical bottlenecks in acute care radiology.
Carlsmed (Nasdaq:CARL) announced today that it began the U.S. launch of its Aprevo technology platform for cervical fusion surgeries.
ST. PAUL, Minn., Dec. 3, 2025 /PRNewswire/ — Astrin Biosciences, a cancer intelligence company transforming how cancer is detected and treated through deep proteomics and AI, announced the launch of Certitude™, the first-of-its-kind, non-imaging, blood-based early cancer detection test. Results from the latest study will be presented at the upcoming San Antonio Breast Cancer Symposium (SABCS), taking place December 10–14, 2025.
Eko Health announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized national payment for its Sensora platform.
Philips (NYSE: PHG)+ has announced the launch of what it calls the world’s first detector-based spectral CT fully powered by AI.
CLEVELAND, Dec. 1, 2025 /PRNewswire/ — MediView XR, Inc., a pioneer in clinical augmented reality and spatial computing, proudly announced its first CE mark certification, a significant regulatory milestone that enables the introduction of its innovative mixed reality solutions across Europe.
CHICAGO, Dec. 1, 2025 /PRNewswire/ — Rad AI, the leader in AI-powered radiology workflow solutions, today announced the launch of next-generation speech recognition technology (patent pending) that dramatically improves the speed and accuracy of diagnostic reporting. Integrated into Rad AI Reporting, the new capabilities deliver unprecedented speed and accuracy, setting a new standard for dictation in radiology.